Cargando…

Substitution of Mannan-Binding Lectin (MBL)-Deficient Serum With Recombinant MBL Results in the Formation of New MBL/MBL-Associated Serine Protease Complexes

The lectin pathway (LP) of complement activation depends on the activation of the MBL-associated serine proteases (MASPs) circulating in complex with mannan-binding lectin (MBL). MBL deficiency is the most common complement deficiency and has been associated with several pathological conditions. As...

Descripción completa

Detalles Bibliográficos
Autores principales: Keizer, Mischa P., Kamp, Angela, van Mierlo, Gerard, Kuijpers, Taco W., Wouters, Diana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030254/
https://www.ncbi.nlm.nih.gov/pubmed/29997613
http://dx.doi.org/10.3389/fimmu.2018.01406
_version_ 1783337110013476864
author Keizer, Mischa P.
Kamp, Angela
van Mierlo, Gerard
Kuijpers, Taco W.
Wouters, Diana
author_facet Keizer, Mischa P.
Kamp, Angela
van Mierlo, Gerard
Kuijpers, Taco W.
Wouters, Diana
author_sort Keizer, Mischa P.
collection PubMed
description The lectin pathway (LP) of complement activation depends on the activation of the MBL-associated serine proteases (MASPs) circulating in complex with mannan-binding lectin (MBL). MBL deficiency is the most common complement deficiency and has been associated with several pathological conditions. As we had previously shown, plasma-derived MBL (pdMBL) contains pre-activated MASPs that upon in vivo pdMBL substitution results in restoration of MBL concentrations but no LP functionality due to immediate inactivation of pdMBL–MASP complexes upon infusion. In this study, we analyzed MBL-sufficient and -deficient serum by size-exclusion chromatography for complexes of LP activation. In both sera, we identified non-bound free forms of MASP-2 and to lesser extent MASP-1/3. After addition of recombinant MBL (rMBL) to MBL-deficient serum, these free MASPs were much less abundantly present, which is highly suggestive for the formation of high-molecular complexes that could still become activated upon subsequent ligand binding as shown by a restoration of C4-deposition of MBL-deficient serum. Ficolin (FCN)-associated MASPs have been described to redistribute to ligand-bound MBL, hereby forming new MBL/MASP complexes. However, reconstitution of MBL-deficient serum with rMBL did not change the relative size of the FCN molecules suggestive for a limited redistribution in fluid phase of already formed complexes. Our findings demonstrate that rMBL can associate with free non-bound MASPs in fluid phase while preserving full restoration of LP functionality. In contrast to pdMBL products containing pre-activated MASPs which become inactivated almost immediately, these current data provide a rationale for substitution studies using rMBL instead.
format Online
Article
Text
id pubmed-6030254
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-60302542018-07-11 Substitution of Mannan-Binding Lectin (MBL)-Deficient Serum With Recombinant MBL Results in the Formation of New MBL/MBL-Associated Serine Protease Complexes Keizer, Mischa P. Kamp, Angela van Mierlo, Gerard Kuijpers, Taco W. Wouters, Diana Front Immunol Immunology The lectin pathway (LP) of complement activation depends on the activation of the MBL-associated serine proteases (MASPs) circulating in complex with mannan-binding lectin (MBL). MBL deficiency is the most common complement deficiency and has been associated with several pathological conditions. As we had previously shown, plasma-derived MBL (pdMBL) contains pre-activated MASPs that upon in vivo pdMBL substitution results in restoration of MBL concentrations but no LP functionality due to immediate inactivation of pdMBL–MASP complexes upon infusion. In this study, we analyzed MBL-sufficient and -deficient serum by size-exclusion chromatography for complexes of LP activation. In both sera, we identified non-bound free forms of MASP-2 and to lesser extent MASP-1/3. After addition of recombinant MBL (rMBL) to MBL-deficient serum, these free MASPs were much less abundantly present, which is highly suggestive for the formation of high-molecular complexes that could still become activated upon subsequent ligand binding as shown by a restoration of C4-deposition of MBL-deficient serum. Ficolin (FCN)-associated MASPs have been described to redistribute to ligand-bound MBL, hereby forming new MBL/MASP complexes. However, reconstitution of MBL-deficient serum with rMBL did not change the relative size of the FCN molecules suggestive for a limited redistribution in fluid phase of already formed complexes. Our findings demonstrate that rMBL can associate with free non-bound MASPs in fluid phase while preserving full restoration of LP functionality. In contrast to pdMBL products containing pre-activated MASPs which become inactivated almost immediately, these current data provide a rationale for substitution studies using rMBL instead. Frontiers Media S.A. 2018-06-27 /pmc/articles/PMC6030254/ /pubmed/29997613 http://dx.doi.org/10.3389/fimmu.2018.01406 Text en Copyright © 2018 Keizer, Kamp, van Mierlo, Kuijpers and Wouters. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Keizer, Mischa P.
Kamp, Angela
van Mierlo, Gerard
Kuijpers, Taco W.
Wouters, Diana
Substitution of Mannan-Binding Lectin (MBL)-Deficient Serum With Recombinant MBL Results in the Formation of New MBL/MBL-Associated Serine Protease Complexes
title Substitution of Mannan-Binding Lectin (MBL)-Deficient Serum With Recombinant MBL Results in the Formation of New MBL/MBL-Associated Serine Protease Complexes
title_full Substitution of Mannan-Binding Lectin (MBL)-Deficient Serum With Recombinant MBL Results in the Formation of New MBL/MBL-Associated Serine Protease Complexes
title_fullStr Substitution of Mannan-Binding Lectin (MBL)-Deficient Serum With Recombinant MBL Results in the Formation of New MBL/MBL-Associated Serine Protease Complexes
title_full_unstemmed Substitution of Mannan-Binding Lectin (MBL)-Deficient Serum With Recombinant MBL Results in the Formation of New MBL/MBL-Associated Serine Protease Complexes
title_short Substitution of Mannan-Binding Lectin (MBL)-Deficient Serum With Recombinant MBL Results in the Formation of New MBL/MBL-Associated Serine Protease Complexes
title_sort substitution of mannan-binding lectin (mbl)-deficient serum with recombinant mbl results in the formation of new mbl/mbl-associated serine protease complexes
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030254/
https://www.ncbi.nlm.nih.gov/pubmed/29997613
http://dx.doi.org/10.3389/fimmu.2018.01406
work_keys_str_mv AT keizermischap substitutionofmannanbindinglectinmbldeficientserumwithrecombinantmblresultsintheformationofnewmblmblassociatedserineproteasecomplexes
AT kampangela substitutionofmannanbindinglectinmbldeficientserumwithrecombinantmblresultsintheformationofnewmblmblassociatedserineproteasecomplexes
AT vanmierlogerard substitutionofmannanbindinglectinmbldeficientserumwithrecombinantmblresultsintheformationofnewmblmblassociatedserineproteasecomplexes
AT kuijperstacow substitutionofmannanbindinglectinmbldeficientserumwithrecombinantmblresultsintheformationofnewmblmblassociatedserineproteasecomplexes
AT woutersdiana substitutionofmannanbindinglectinmbldeficientserumwithrecombinantmblresultsintheformationofnewmblmblassociatedserineproteasecomplexes